(Q33871614)

29 July 2017

1 reference

title

Drug interactions of the newer oral antifungal agents (English)

1 reference

29 July 2017

Katz HI

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

British Journal of Dermatology

29 July 2017

published in

1 reference

29 July 2017

volume

141 Suppl 56

1 reference

29 July 2017

page(s)

26-32

1 reference

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Current issues in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Oral antifungal drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Systemic antifungal agents. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Optimisation of itraconazole therapy using target drug concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Terbinafine. An update of its use in superficial mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Pharmacokinetic drug interactions with antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Clinical importance of hepatic cytochrome P450 in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Recent advances: the cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Interaction between warfarin and oral terbinafine. Manufacturer does not agree that interaction was with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Clinical singgnificance of interactions with antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Interaction between terbinafine and warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Serious interaction between warfarin and oral terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

Investigation of terbinafine as a CYP2D6 inhibitor in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1999.00011.X

10.1046/J.1365-2133.1999.00011.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference